Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population

References

• Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer. 2005;5:699–712. doi:10.1038/nrc1696. PMID: 16110318
   PubMed Web of Science ®Google Scholar
• Weirich A, Ludwig R, Graf N, Abel U, Leuschner I, Vujanic GM, Mehls O, Boos J, Beck J, Royer-Pokora B, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004;15:808–820. doi:10.1093/annonc/mdh171. PMID: 15111352
   PubMed Web of Science ®Google Scholar
• Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43:705–715. doi:10.1136/jmg.2006.041723. PMID: 16690728
   PubMed Web of Science ®Google Scholar
• Little SE, Hanks SP, King-Underwood L, Jones C, Rapley EA, Rahman N, Pritchard-Jones K. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol. 2004;22:4140–4146. doi:10.1200/JCO.2004.02.136. PMID: 15483024
   PubMed Web of Science ®Google Scholar
• Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet. 2008;40:1329–1334. doi:10.1038/ng.243. PMID: 18836444
   PubMed Web of Science ®Google Scholar
• Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell. 2008;14:10–21. doi:10.1016/j.ccr.2008.06.001. PMID: 18598940
   PubMed Web of Science ®Google Scholar
• Zhang L, Anglesio MS, O'Sullivan M, Zhang F, Yang G, Sarao R, Mai PN, Cronin S, Hara H, Melnyk N, et al. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. Nat Med. 2007;13:1060–1069. doi:10.1038/nm1621. PMID: 17694067
   PubMed Web of Science ®Google Scholar
• Diskin SJ, Capasso M, Schnepp RW, Cole KA, Attiyeh EF, Hou C, Diamond M, Carpenter EL, Winter C, Lee H, et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet. 2012;44:1126–1130. doi:10.1038/ng.2387. PMID: 22941191
   PubMed Web of Science ®Google Scholar
• Turnbull C, Perdeaux ER, Pernet D, Naranjo A, Renwick A, Seal S, Munoz-Xicola RM, Hanks S, Slade I, Zachariou A, et al. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet. 2012;44:681–684. doi:10.1038/ng.2251. PMID: 22544364
   PubMedGoogle Scholar
• Zhang Z, Zhang R, Zhu J, Wang F, Yang T, Zou Y, He J, Xia H. Common variations within HACE1 gene and neuroblastoma susceptibility in a Southern Chinese population. Onco Targets Ther. 2017;10:703–709. doi:10.2147/OTT.S129042. PMID: 28223827
   PubMed Web of Science ®Google Scholar
• Fu W, Zhu J, Xiong SW, Jia W, Zhao Z, Zhu SB, Hu JH, Wang FH, Xia H, He J, et al. BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility. EBioMedicine. 2017;16:101–105. doi:10.1016/j.ebiom.2017.01.038. PMID: 28161399
   PubMed Web of Science ®Google Scholar
• Fu W, Zhuo ZJ, Jia W, Zhu J, Zhu SB, Lin ZF, Wang FH, Xia H, He J, Liu GC. Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population. Onco Targets Ther. 2017;10:1149–1154. doi:10.2147/OTT.S131014. PMID: 28260929
   PubMed Web of Science ®Google Scholar
• Fu W, Liu GC, Zhao Z, Zhu J, Jia W, Zhu SB, Hu JH, Wang FH, He J, Xia H. The correlation between LIN28B gene potentially functional variants and Wilms tumor susceptibility in Chinese children. J Clin Lab Anal. 2017; doi:10.1002/jcla.22200. PMID: 28301057
   PubMedGoogle Scholar
• He J, Zhang R, Zou Y, Zhu J, Yang T, Wang F, Xia H. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population. Tumour Biol. 2016;37:1635–1639. doi:10.1007/s13277-015-3936-7. PMID: 26307394
   PubMedGoogle Scholar
• Zhang R, Zou Y, Zhu J, Zeng X, Yang T, Wang F, He J, Xia H. The association between GWAS-identified BARD1 Gene SNPs and neuroblastoma susceptibility in a Southern Chinese population. Int J Med Sci. 2016;13:133–138. doi:10.7150/ijms.13426. PMID: 26941572
   PubMed Web of Science ®Google Scholar
• He J, Wang F, Zhu J, Zhang Z, Zou Y, Zhang R, Yang T, Xia H. The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children. Aging. 2017;9:852–859. PMID: 28275206
   PubMedGoogle Scholar
• Lou J, Gong J, Ke J, Tian J, Zhang Y, Li J, Yang Y, Zhu Y, Gong Y, Li L, et al. A functional polymorphism located at transcription factor binding sites, rs6695837 near LAMC1 gene, confers risk of colorectal cancer in Chinese populations. Carcinogenesis. 2017;38:177–183. PMID: 28039327
   PubMed Web of Science ®Google Scholar
• Li J, Zou L, Zhou Y, Li L, Zhu Y, Yang Y, Gong Y, Lou J, Ke J, Zhang Y, et al. A low-frequency variant in SMAD7 modulates TGF-beta signaling and confers risk for colorectal cancer in Chinese population. Mol Carcinog. 2017;56:1798–1807. doi:10.1002/mc.22637. PMID: 28218435
   PubMed Web of Science ®Google Scholar
• He J, Qiu LX, Wang MY, Hua RX, Zhang RX, Yu HP, Wang YN, Sun MH, Zhou XY, Yang YJ, et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet. 2012;131:1235–1244. doi:10.1007/s00439-012-1152-8. PMID: 22371296
   PubMed Web of Science ®Google Scholar
• Hua RX, Zhu J, Jiang DH, Zhang SD, Zhang JB, Xue WQ, Li XZ, Zhang PF, He J, Jia WH. Association of XPC gene polymorphisms with colorectal cancer risk in a Southern Chinese population: A case-control study and meta-analysis. Genes. 2016;7:E73. doi:10.3390/genes7100073. PMID: 27669310
   PubMed Web of Science ®Google Scholar
• Hua RX, Zhuo ZJ, Zhu J, Zhang SD, Xue WQ, Zhang JB, Xu HM, Li XZ, Zhang PF, He J, et al. XPG gene polymorphisms contribute to colorectal cancer susceptibility: a two-stage case-control study. J Cancer. 2016;7:1731–1739. doi:10.7150/jca.15602. PMID: 27698911
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang M, He J, Zhu M, Wang JC, Jin L, Wang XF, Yang YJ, Xiang JQ, Wei Q. Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population. J Cell Mol Med. 2016;20:666–677. doi:10.1111/jcmm.12750. PMID: 26828791
   PubMed Web of Science ®Google Scholar
• Beckwith JB. National Wilms tumor study: an update for pathologists. Pediatr Dev Pathol. 1998;1:79–84. doi:10.1007/s100249900010. PMID: 10463275
   PubMed Web of Science ®Google Scholar
• Castillo-Lluva S, Tan CT, Daugaard M, Sorensen PH, Malliri A. The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation. Oncogene. 2013;32:1735–1742. doi:10.1038/onc.2012.189. PMID: 22614015
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang Z, Vucetic Z, Soprano KJ, Soprano DR. HACE1: A novel repressor of RAR transcriptional activity. J Cell Biochem. 2009;107:482–493. doi:10.1002/jcb.22146. PMID: 19350571
   PubMed Web of Science ®Google Scholar
• Huang Y, de Reynies A, de Leval L, Ghazi B, Martin-Garcia N, Travert M, Bosq J, Brière J, Petit B, Thomas E, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood. 2010;115:1226–1237. doi:10.1182/blood-2009-05-221275. PMID: 19965620
   PubMed Web of Science ®Google Scholar
• Hibi K, Sakata M, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, et al. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Anticancer Res. 2008;28:1581–1584. PMID: 18630515
   PubMed Web of Science ®Google Scholar
• Sakata M, Kitamura YH, Sakuraba K, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y, et al. Methylation of HACE1 in gastric carcinoma. Anticancer Res. 2009;29:2231–2233. PMID: 19528486
   PubMed Web of Science ®Google Scholar
• Goka ET, Lippman ME. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression. Oncogene. 2015;34:5395–5405. doi:10.1038/onc.2014.468. PMID: 25659579
   PubMed Web of Science ®Google Scholar
• Capasso M, Diskin SJ, Totaro F, Longo L, De Mariano M, Russo R, Cimmino F, Hakonarson H, Tonini GP, Devoto M, et al. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Carcinogenesis. 2013;34:605–ss611. doi:10.1093/carcin/bgs380. PMID: 23222812
   PubMed Web of Science ®Google Scholar
• Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, Pritchard-Jones K, Cole R, Pizer B, Stiller C, et al. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet. 2010;47:342–347. doi:10.1136/jmg.2009.072983. PMID: 19948536
   PubMed Web of Science ®Google Scholar